Annual total expenses:
$13.18B+$530.00M(+4.19%)Summary
- As of today (May 30, 2025), TEVA annual total expenses is $13.18 billion, with the most recent change of +$530.00 million (+4.19%) on December 31, 2024.
- During the last 3 years, TEVA annual total expenses has risen by +$402.00 million (+3.15%).
- TEVA annual total expenses is now -26.20% below its all-time high of $17.86 billion, reached on December 31, 2017.
Performance
TEVA Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$3.19B-$123.00M(-3.72%)Summary
- As of today (May 30, 2025), TEVA quarterly total expenses is $3.19 billion, with the most recent change of -$123.00 million (-3.72%) on March 31, 2025.
- Over the past year, TEVA quarterly total expenses has increased by +$8.00 million (+0.25%).
- TEVA quarterly total expenses is now -39.62% below its all-time high of $5.28 billion, reached on December 31, 2016.
Performance
TEVA Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TEVA Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.2% | +0.3% |
3 y3 years | +3.1% | +7.1% |
5 y5 years | -7.0% | -6.8% |
TEVA Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +7.7% | -4.9% | +9.0% |
5 y | 5-year | -7.0% | +7.7% | -14.8% | +9.0% |
alltime | all time | -26.2% | >+9999.0% | -39.6% | +1556.3% |
TEVA Total expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $3.19B(-3.7%) |
Dec 2024 | $13.18B(+4.2%) | $3.31B(-1.2%) |
Sep 2024 | - | $3.35B(-0.0%) |
Jun 2024 | - | $3.35B(+5.4%) |
Mar 2024 | - | $3.18B(+0.2%) |
Dec 2023 | $12.65B(+3.4%) | $3.17B(+2.4%) |
Sep 2023 | - | $3.10B(-4.2%) |
Jun 2023 | - | $3.23B(+2.5%) |
Mar 2023 | - | $3.15B(-2.9%) |
Dec 2022 | $12.23B(-4.3%) | $3.25B(+11.2%) |
Sep 2022 | - | $2.92B(-5.6%) |
Jun 2022 | - | $3.09B(+4.0%) |
Mar 2022 | - | $2.97B(-9.2%) |
Dec 2021 | $12.78B(-6.0%) | $3.27B(+3.1%) |
Sep 2021 | - | $3.18B(+2.5%) |
Jun 2021 | - | $3.10B(-4.0%) |
Mar 2021 | - | $3.23B(-13.6%) |
Dec 2020 | $13.60B(-4.0%) | $3.74B(+14.7%) |
Sep 2020 | - | $3.26B(+2.4%) |
Jun 2020 | - | $3.18B(-6.9%) |
Mar 2020 | - | $3.42B(-9.9%) |
Dec 2019 | $14.17B(-8.0%) | $3.80B(+12.7%) |
Sep 2019 | - | $3.37B(-4.1%) |
Jun 2019 | - | $3.51B(+0.7%) |
Mar 2019 | - | $3.49B(+1.4%) |
Dec 2018 | $15.40B(-13.8%) | $3.44B(-11.1%) |
Sep 2018 | - | $3.87B(-2.1%) |
Jun 2018 | - | $3.96B(-4.3%) |
Mar 2018 | - | $4.13B(+4.9%) |
Dec 2017 | $17.86B(+3.2%) | $3.94B(-16.4%) |
Sep 2017 | - | $4.71B(+1.6%) |
Jun 2017 | - | $4.64B(+1.6%) |
Mar 2017 | - | $4.57B(-13.4%) |
Dec 2016 | $17.30B(+18.0%) | $5.28B(+12.8%) |
Sep 2016 | - | $4.67B(+23.1%) |
Jun 2016 | - | $3.80B(+7.0%) |
Mar 2016 | - | $3.55B(-6.7%) |
Dec 2015 | $14.66B(-7.1%) | $3.81B(+8.5%) |
Sep 2015 | - | $3.51B(-3.5%) |
Jun 2015 | - | $3.63B(-1.9%) |
Mar 2015 | - | $3.71B(-7.0%) |
Dec 2014 | $15.78B(-3.5%) | $3.98B(+2.0%) |
Sep 2014 | - | $3.90B(-1.2%) |
Jun 2014 | - | $3.95B(+0.2%) |
Mar 2014 | - | $3.94B(-10.3%) |
Dec 2013 | $16.35B(+1.3%) | $4.39B(+8.7%) |
Sep 2013 | - | $4.04B(+1.9%) |
Jun 2013 | - | $3.97B(+0.7%) |
Mar 2013 | - | $3.94B(-7.9%) |
Dec 2012 | $16.14B(+12.8%) | $4.28B(+9.7%) |
Sep 2012 | - | $3.90B(-0.8%) |
Jun 2012 | - | $3.93B(-2.3%) |
Mar 2012 | - | $4.03B(-10.9%) |
Dec 2011 | $14.30B(+20.8%) | $4.52B(+38.6%) |
Sep 2011 | - | $3.26B(-2.5%) |
Jun 2011 | - | $3.34B(+5.0%) |
Mar 2011 | - | $3.18B(-4.1%) |
Dec 2010 | $11.84B | $3.32B(+10.4%) |
Sep 2010 | - | $3.01B(+10.6%) |
Jun 2010 | - | $2.72B(-2.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $2.78B(-3.8%) |
Dec 2009 | $10.83B(+10.4%) | $2.89B(+7.1%) |
Sep 2009 | - | $2.70B(+2.0%) |
Jun 2009 | - | $2.65B(+2.0%) |
Mar 2009 | - | $2.60B(-26.8%) |
Dec 2008 | $9.82B(+40.0%) | $3.55B(+61.8%) |
Sep 2008 | - | $2.19B(+0.3%) |
Jun 2008 | - | $2.19B(+15.4%) |
Mar 2008 | - | $1.89B(-1.1%) |
Dec 2007 | $7.01B(+11.1%) | $1.92B(+11.7%) |
Sep 2007 | - | $1.72B(-1.9%) |
Jun 2007 | - | $1.75B(+7.0%) |
Mar 2007 | - | $1.63B(-11.9%) |
Dec 2006 | $6.31B(+60.3%) | $1.85B(+18.7%) |
Sep 2006 | - | $1.56B(+4.3%) |
Jun 2006 | - | $1.50B(+9.5%) |
Mar 2006 | - | $1.37B(+31.4%) |
Dec 2005 | $3.94B(+8.7%) | $1.04B(+3.5%) |
Sep 2005 | - | $1.01B(+9.4%) |
Jun 2005 | - | $918.60M(-5.7%) |
Mar 2005 | - | $974.00M(-1.3%) |
Dec 2004 | $3.62B(+51.5%) | $986.90M(+6.2%) |
Sep 2004 | - | $929.60M(+5.7%) |
Jun 2004 | - | $879.30M(+6.2%) |
Mar 2004 | - | $828.20M(+15.8%) |
Dec 2003 | $2.39B(+19.9%) | $715.50M(+16.2%) |
Sep 2003 | - | $615.50M(+27.6%) |
Jun 2003 | - | $482.50M(-16.5%) |
Mar 2003 | - | $578.10M(-1.6%) |
Dec 2002 | $1.99B(+17.3%) | $587.60M(+15.3%) |
Sep 2002 | - | $509.70M(+10.7%) |
Jun 2002 | - | $460.40M(+5.4%) |
Mar 2002 | - | $436.90M(-4.0%) |
Dec 2001 | $1.70B(+23.7%) | $455.31M(+12.0%) |
Sep 2001 | - | $406.70M(-4.7%) |
Jun 2001 | - | $426.74M(+3.6%) |
Mar 2001 | - | $412.02M(+20.3%) |
Dec 2000 | $1.37B(+35.4%) | $342.52M(-8.8%) |
Sep 2000 | - | $375.63M(+0.1%) |
Jun 2000 | - | $375.16M(+33.3%) |
Mar 2000 | - | $281.34M(+12.6%) |
Dec 1999 | $1.01B(+11.3%) | $249.84M(-7.3%) |
Sep 1999 | - | $269.50M(+8.2%) |
Jun 1999 | - | $249.00M(+0.9%) |
Mar 1999 | - | $246.70M(+28.3%) |
Dec 1998 | $912.19M(-3.3%) | $192.29M(-27.1%) |
Sep 1998 | - | $263.60M(+17.9%) |
Jun 1998 | - | $223.50M(-4.1%) |
Mar 1998 | - | $233.00M |
Dec 1997 | $943.10M(+14.4%) | - |
Dec 1996 | $824.50M(+16.6%) | - |
Dec 1995 | $707.10M(+13.2%) | - |
Dec 1994 | $624.80M(+50.9%) | - |
Dec 1993 | $414.00M(+21.2%) | - |
Dec 1992 | $341.60M(+24.2%) | - |
Dec 1991 | $275.00M(-4.7%) | - |
Dec 1990 | $288.70M(+21.9%) | - |
Dec 1989 | $236.90M(+25.6%) | - |
Dec 1988 | $188.60M(+56.8%) | - |
Mar 1987 | $120.30M(+51.7%) | - |
Mar 1986 | $79.30M | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual total expenses?
- What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly total expenses?
- What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?
What is Teva Pharmaceutical Industries Limited annual total expenses?
The current annual total expenses of TEVA is $13.18B
What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual total expenses is $17.86B
What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?
Over the past year, TEVA annual total expenses has changed by +$530.00M (+4.19%)
What is Teva Pharmaceutical Industries Limited quarterly total expenses?
The current quarterly total expenses of TEVA is $3.19B
What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly total expenses is $5.28B
What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?
Over the past year, TEVA quarterly total expenses has changed by +$8.00M (+0.25%)